Insight Partners, a private equity firm, led a $28m Series C funding round in ScreenPoint, a company that develops and markets image analysis and machine learning applications and services to improve early detection of breast cancer. Additional investors include Oost NL, University Radiology Group and Siemens Healthineers. "We are excited about this funding and the opportunity to work with the Insight Partners team to continue scaling the company. We are also delighted with the participation of URG in this round, showing trust and confidence in the technology we bring to the market. Breast imaging practice in the US is different from the EU, and the partnership with URG brings clinical expertise, which is extremely valuable for further expansion in the US. This round puts ScreenPoint Medical in a great position to establish itself as the leading provider of AI driven solutions for breast imaging," Nico Karssemeijer, ScreenPoint Medical CEO.